Patent · US Expired

Peptides and peptidomimetics useful for inhibiting the activity of prostaglandin F2α receptor

US7521530B2 · kind B2 · utility

15Cited by
11References
6Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 11, 2002
Grant dateApr 21, 2009
Priority date
Expiry dateJun 11, 2022

Classification

  • Technology area (CPC A)Human Necessities
  • CPC primaryA61K38/00
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention relates to compositions which are useful for inhibiting prostaglandin F2αreceptor. The compositions include, but are not limited to, linear peptides, peptide analogs, and peptidomimetics. Methods of using the compositions of the invention to treat preterm labor and dysmenorrhea are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.